JESSE MACE: Open Payments
NPI 1275975237 · VERO BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,474 in 42 payments from 14 companies in 2025. Trend: 2023 $1,493 · 2024 $632 · 2025 $1,474
Food & beverage: $1,474
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $299 |
| Grifols USA, LLC | 8 | $259 |
| Novo Nordisk Inc | 7 | $227 |
| ABBVIE INC. | 4 | $185 |
| AtriCure, Inc. | 1 | $157 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $104 |
| Insmed, Inc. | 2 | $54 |
| Astellas Pharma US Inc | 3 | $47 |
| Lilly USA, LLC | 2 | $37 |
| Exact Sciences Corporation | 1 | $28 |
Products named: Prolastin-C Liquid, Ozempic, AIRSUPRA, QULIPTA, EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, BREZTRI, Arikayce, Veozah.
Industry payments across FL — which companies pay providers there.
